title: Immunological responses to oxidized LDL.
abstract: Considerable evidence now points to an important role for the immune system in experimental models of atherosclerosis. We have reviewed the growing body of evidence that oxidation of LDL generates a wide variety of neoself determinants that lead to cellular and humoral immune responses. In particular, we have demonstrated that at least some of the oxidation-specific epitopes generated on the oxidized LDL particle, such as oxidized phospholipid epitopes, are also generated on apoptotic cells and are also present on the surface of some bacteria. Many of these same epitopes serve as important ligands mediating the binding and clearance of oxidatively damaged lipoprotein particles and apoptotic cells, and the innate immune response to these epitopes can be seen as a concerted response to effect their removal. In addition, other epitopes of OxLDL also undoubtedly play a role in the immune activation that characterizes the progressive atherosclerotic plaque. It will be of great importance to define the importance of the role of these responses and to understand which are beneficial and which deleterious. Such information could lead one day to novel therapeutic approaches to inhibit atherogenesis that take advantage of the ability to manipulate the immune response.
authors.affiliation: Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0682, USA.
authors.forename: S
authors.initials: S
authors.lastname: Hörkkö
authors.forename: C J
authors.initials: CJ
authors.lastname: Binder
authors.forename: P X
authors.initials: PX
authors.lastname: Shaw
authors.forename: M K
authors.initials: MK
authors.lastname: Chang
authors.forename: G
authors.initials: G
authors.lastname: Silverman
authors.forename: W
authors.initials: W
authors.lastname: Palinski
authors.forename: J L
authors.initials: JL
authors.lastname: Witztum
mesh_terms: D000447:Aldehydes / Q000378:metabolism; D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000097:blood / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000235:genetics; D016736:Antiphospholipid Syndrome / Q000276:immunology; D001057:Apolipoproteins E / Q000172:deficiency; D017209:Apoptosis / Q000276:immunology; D001161:Arteriosclerosis / Q000276:immunology* / Q000378:metabolism; D001323:Autoantibodies / Q000097:blood; D002308:Cardiolipins / Q000276:immunology / Q000378:metabolism; D000939:Epitopes / Q000096:biosynthesis / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D008077:Lipoproteins, LDL / Q000276:immunology* / Q000378:metabolism; D008315:Malondialdehyde / Q000378:metabolism; D051379:Mice; D011225:Pre-Eclampsia / Q000276:immunology; D011247:Pregnancy
chemical_list: D000447:Aldehydes; D017152:Antibodies, Antiphospholipid; D000911:Antibodies, Monoclonal; D001057:Apolipoproteins E; D001323:Autoantibodies; D002308:Cardiolipins; D000939:Epitopes; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D008315:Malondialdehyde; C027576:4-hydroxy-2-nonenal